Alexey Gordeev

Alexey Gordeev

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
LKLyudmila Korostovtseva
Lyudmila Korostovtseva
MBMikhail Bochkarev
Mikhail Bochkarev
VAValeria Amelina
Valeria Amelina
UNUliana Nikishkina
Uliana Nikishkina
SOSofia Osipenko
Sofia Osipenko
AKAleksandra Konradi
Aleksandra Konradi
Background: Sleep-disordered breathing (SDB) is highly prevalent after stroke and is considered to be a risk factor for poor post-stroke outcomes. The aim of this observational study was to evaluate the effect of nocturnal respiratory-related indices based on nocturnal respiratory polygraphy on clinical outcomes (including mortality and non-fatal events) in patients with ischemic stroke. Methods: A total of 328 consecutive patients (181 (55%) males, mean age 65.8 ± 11.2 years old) with confirmed ischemic stroke admitted to a stroke unit within 24 h after stroke onset were included in the analysis. All patients underwent standard diagnostic and treatment procedures, and sleep polygraphy was performed within the clinical routine in the first 72 h after admission. The long-term outcomes were assessed by cumulative endpoint (death of any cause, new non-fatal myocardial infarction, new non-fatal stroke/transient ischemic attack, emergency revascularization, emergency hospitalization due to the worsening of cardiovascular disease). A Cox-regression analysis was applied to evaluate the effects of nocturnal respiratory indices on survival. Results: The mean follow-up period comprised 12 months (maximal—48 months). Patients with unfavourable outcomes demonstrated a higher obstructive apnea-hypopnea index, a higher hypoxemia burden assessed as a percent of the time with SpO2 < 90%, a higher average desaturation drop, and a higher respiratory rate at night. Survival time was significantly lower (30.6 (26.5; 34.7) versus 37.9 (34.2; 41.6) months (Log Rank 6.857, p = 0.009)) in patients with higher hypoxemia burden (SpO2 < 90% during ≥2.1% versus <2.1% of total analyzed time). However, survival time did not differ depending on the SDB presence assessed by AHI thresholds (either ≥5 or ≥15/h). The multivariable Cox proportional hazards regression (backward stepwise analysis) model demonstrated that the parameters of hypoxemia burden were significantly associated with survival time, independent of age, stroke severity, stroke-related medical interventions, comorbidities, and laboratory tests. Conclusion: Our study demonstrates that the indices of hypoxemia burden have additional independent predictive value for long-term outcomes (mortality and non-fatal cardiovascular events) after ischemic stroke.

2 December 2021 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
MBMikhail Bochkarev
Mikhail Bochkarev
MKM. A. Kulakova
M. A. Kulakova
VKV. V. Kemstach
V. V. Kemstach
AGAlexey Gordeev
Alexey Gordeev
EZE. A. Zabroda
E. A. Zabroda
YSYu. V. Sviryaev
Yu. V. Sviryaev
Objective. To assess subjective and objective sleep characteristics and urinary metanephrine levels in patients with insomnia. Design and methods. We included patients with insomnia complaints and those without sleep– related complaints (control group) 18–75 years old. Subjective evaluation of the main sleep characteristics during the last month was assessed by the Pittsburgh Sleep Quality questionnaire, daytime sleepiness — by the Epworth Sleepiness Scale. For objective sleep evaluation we performed one-night polysomnography (PSG). Within 1 week after the PSG, daily urine was collected to determine the level of metaepinephrine. Results. The groups did not differ by age, mean sleep duration over the past month, number of night awakenings by the Pittsburgh Questionnaire, and level of daytime sleepiness. Sleep latency in insomnia group was 15 minutes longer than in the control group. PSG showed higher apnea-hypopnea and desaturation indices in the control group. There were no differences in daily urinary metanephrine excretion in the main and control groups. Correlation analysis showed no significant association between the metanephrine levels and the severity of somnolence and the index of periodic limb movements. Conclusions. Our analysis showed no significant differences in the daily urine metanephrine levels and the main PSG sleep characteristics among subjects with and without insomnia. Further work is required to clarify markers of insomnia and their negative health effects.

8 November 2022 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
AGAlexey Gordeev
Alexey Gordeev
MBMikhail Bochkarev
Mikhail Bochkarev
LKLyudmila Korostovtseva
Lyudmila Korostovtseva
EZE. N. Zabroda
E. N. Zabroda
VAV. V. Amelina
V. V. Amelina
AAA. N. Alekhin
A. N. Alekhin
Objective. To identify objective measures of sleep and molecular markers of sleep reactivity to stress to determine its role for insomnia prevention and management. Design and methods. The sample included 42 subjects with sleep disturbances and 23 subjects without sleep-related complaints (control group) aged 18 to 72 years. Altogether there are 19 men and 55 women. Nine participants were excluded from the study. Sleep reactivity to stress was assessed using the Ford Insomnia Response to Stress Test (FIRST) questionnaire. The Integrative Anxiety Test was used to screen for anxiety. Sleep indices were assessed by polysomnography (PSG). Blood plasma samples were collected in the morning after PSG to determine brain-derived neurotrophic factor (BDNF), and 24-hour urine was collected one week after PSG to assess metanephrine levels. Results. There were 64 % healthy subjects with low sleep reactivity to stress and low anxiety and 79 % subjects showed insomnia among persons with high sleep reactivity and anxiety. Significant differences in PSG measures were found in groups with low and high sleep reactivity: the efficiency of sleep and the percentage of the second stage of NREM sleep were higher in group with low reactivity, also sleep latency and wake time after sleep onset were lower in group with high reactivity. In addition, serum BDNF level was significantly higher in group with low reactivity, and it correlates positively with daily urinary metanephrine excretion and the absolute duration of stage N3 and negatively with sleep latency. Conclusions. Subjects with high reactivity to stress have lower sleep quality and depth that corresponds to other studies. The level of BDNF is a possible marker of sleep reactivity to stress and it can indicate the potential adaptation to stress.

Verified
Journal Article
Open access
PDF file
YBYury Yu. Borshchev
Yury Yu. Borshchev
IBInessa Yu. Burovenko
Inessa Yu. Burovenko
A(Alena Zalicheva (Karaseva)
Alena Zalicheva (Karaseva)
SMSarkis M. Minasian
Sarkis M. Minasian
AGAlexey Gordeev
Alexey Gordeev
MGMichael Galagudza
Michael Galagudza
In this study, we investigated the role of mitochondrial and sarcolemmal ATP-sensitive potassium channels (mKATP and sKATP, respectively) in the mechanisms of cardioprotection afforded by a combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) in rats with systemic inflammatory response (SIR), which included diet-induced obesity and chemically induced colitis. Selective mKATP and sKATP blockers were used for assessment of their involvement in the mechanisms of probiotic preconditioning, while myocardial tolerance to ischemia–reperfusion injury was determined in the isolated perfused heart subjected to global ischemia–reperfusion. Intragastric administration of lyophilized LA-5 and BB-12 at a dose of 1.2 × 108 CFU/mL for 7 days resulted in myocardial infarct size reduction. This cardioprotective effect was associated with specific changes in cytokine concentrations, namely, reduced levels of interleukin-1β, tumor necrosis factor-α, and interferon-γ. Moreover, probiotic therapy reversed SIR-induced reduction in the abundance of Lactobacillus spp. in the gut and SIR-induced elevation of acetic and propionic short-chain fatty acids in the blood. Preischemic pharmacological inhibition of sKATP channels but not mKATP channels abolished cardioprotective effect of probiotics. Therefore, it was suggested that sKATP channels are implicated in myocardial protection elicited by probiotics.

23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
EZE.N. Zabroda
E.N. Zabroda
VAV.V. Amelina
V.V. Amelina
AGAlexey Gordeev
Alexey Gordeev
ISI.V. Sakovsky
I.V. Sakovsky
MBMikhail Bochkarev
Mikhail Bochkarev
LKLyudmila Korostovtseva
Lyudmila Korostovtseva
OBJECTIVE To study the relationship between brain-derived neurotrophic factor (BDNF) and the severity of nocturnal hypoxemia in patients in the acute and early recovery period of ischemic stroke (IS). MATERIAL AND METHODS We enrolled 44 patients (27 men, 17 women), aged 18-85 years, in the acute phase of IS. At 3-month follow-up, 35 people were examined (21 men and 14 women). In the acute period, in addition to routine diagnostic procedures, respiratory monitoring was carried out, and the serum level of BDNF was measured by enzyme-linked immunosorbent assay. BDNF level was also evaluated at 3-month follow-up visit. Neurological status and its dynamics in the acute period of stroke were assessed as part of the clinical routine according to the National Institutes of Health Stroke Scale (NIHSS) at admission and discharge. RESULTS We found a direct correlation between the duration of hypoxemia with SpO2 less than 90% (r=0.327, p=0.035) and less than 85% (r=0.461, p=0.003) and BDNF level in the acute phase of IS. BDNF level in the acute period of IS was negatively correlated with the minimum saturation value (r=–0.328, p=0.034). There was a direct relationship between BDNF level in the early recovery period and the duration of hypoxemia with SpO2 less than 85% (r=–0.389, p=0.028). A regression model showed that BDNF level was associated with the minimum SpO2 level. No significant associations were found with indicators of sleep-disordered breathing severity, such as the apnea-hypopnea index and the oxygen desaturation index. CONCLUSION The severity of nocturnal hypoxemia is associated with the increase in BDNF levels both in the acute and recovery periods of IS, regardless of the presence of concomitant breathing disorders during sleep.

13 April 2026 in Bulletin of Siberian Medicine
Verified
Journal Article
Closed access
YBYu. Yu. Borshchev
Yu. Yu. Borshchev
SMS. M. Minasyan
S. M. Minasyan
IBI. Yu. Burovenko
I. Yu. Burovenko
AGAlexey Gordeev
Alexey Gordeev
VBV. Yu. Borshchev
V. Yu. Borshchev
MGMichael Galagudza
Michael Galagudza
Aim. To experimentally test the hypothesis of the participation of MEK1/2 and ERK1/2 kinases in the mechanism of the probiotic cardioprotection in the implementation of the signaling stage of the cardioprotective response to the administration of probiotic strains in the systemic inflammatory response in rats. Materials and methods. The experiments were performed on male Wistar rats using a model of systemic inflammatory response syndrome, which includes obesity and chemically induced colitis. To provide probiotic cardioprotective effects, the animals were administered probiotic strains LA-5 and BB-12 orally. An inhibitor of MEK1/2 kinase and its associated ERK1/2 kinase PD98059 at a dose of 0.3 mg/kg were administered intravenously 20 minutes before the start of Langendorff perfusion of an isolated heart., The size of the necrosis zone (SNZ) was histochemically determined after 30 minutes of global ischemia and 90 minutes of reperfusion were simulated. Markers of the systemic inflammatory response (SIR) were detected in the blood. Results. In the group of rats on the model of SIR in comparison with the control, a significant increase in the number of leukocytes and an increase in the level of proinflammatory cytokines in the blood, as well as a significant increase in SNZ (by 39% in relation to CTR, p < 0.05). In the group with probiotic correction, a significantly lower SNZ was noted in relation to SIR, whereas in rats with the introduction of probiotics and the substance PD98059, SNZ was significantly higher, i.e. the cancellation of the cardioprotective effect of probiotic therapy occurred. Conclusion. Based on the conclusion that the cardioprotective effect has been abolished by PD98059 administration, it can be assumed that the probiotic effect is provided by the MEK1/2 and ERK1/2 kinase pathways.